Select a section from the left sidebar
Butenyl isothiocyanate
- Family: Plantae - Cruciferae-Brassicaceea
- Kingdom: Plantae
- Class: Thiocyanate
Canonical Smiles | CC/C=C/N=C=S |
---|---|
InChI | InChI=1S/C5H7NS/c1-2-3-4-6-5-7/h3-4H,2H2,1H3/b4-3+ |
InChIKey | XDDPFUCCKIMFOG-ONEGZZNKSA-N |
Formula | C5H7NS |
HBA | 2 |
HBD | 0 |
MW | 113.19 |
Rotatable Bonds | 2 |
TPSA | 12.36 |
LogP | 2.01 |
Number Rings | 0 |
Number Aromatic Rings | 0 |
Heavy Atom Count | 7 |
Formal Charge | 0 |
Fraction CSP3 | 0.4 |
Exact Mass | 113.03 |
Number of Lipinski Rule Violations | 0 |
# | Species | Family | Kingdom | NCBI Taxonomy ID |
---|---|---|---|---|
1 | Erucaria microcarpa | Cruciferae-Brassicaceea | Plantae | 1078594 |
Showing of synonyms
Butenyl isothiocyanate
Butenylisothiocyanate
(E)-1-isothiocyanatobut-1-ene
34424-44-7
Butenylisothiocyanat
Butenylisothiocyanat [German]
Isothiocyanic acid, butenyl ester
Butenyl isothiocyanic acid
Bylitc
Isothiocyanic acid, 3-butenyl ester
Butene,1-isothiocyanato- (9CI)
CHEMBL2251722
- Hashem FA, Saleh MM (1999). Antimicrobial components of some cruciferae plants (Diplotaxis harra Forsk. and Erucaria microcarpa Boiss.).. Phytotherapy Research,1999,13(4),329-332. [View]
No compound-protein relationship available.
No scaffolds available.
No bioactivities available.
Absorption
- Caco-2 (logPapp)
- -4.27
- Human Oral Bioavailability 20%
- Bioavailable
- Human Intestinal Absorption
- Absorbed
- Madin-Darby Canine Kidney
- -3.91
- Human Oral Bioavailability 50%
- Bioavailable
- P-Glycoprotein Inhibitor
- Non-Inhibitor
- P-Glycoprotein Substrate
- Non-Substrate
- Skin Permeability
- -3.23
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- Penetrable
- Fraction Unbound (Human)
- 0.15
- Plasma Protein Binding
- 16.64
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- Non-Inhibitor
- CYP 1A2 Inhibitor
- Non-Inhibitor
- CYP 1A2 Substrate
- Substrate
- CYP 2C19 Inhibitor
- Non-Inhibitor
- CYP 2C19 Substrate
- Non-Substrate
- CYP 2C9 Inhibitor
- Non-Inhibitor
- CYP 2C9 Substrate
- Non-Substrate
- CYP 2D6 Inhibitor
- Inhibitor
- CYP 2D6 Substrate
- Substrate
- CYP 3A4 Inhibitor
- Non-Inhibitor
- CYP 3A4 Substrate
- Non-Substrate
- OATP1B1
- Non-Inhibitor
- OATP1B3
- Non-Inhibitor
Excretion
- Clearance
- 9.1
- Organic Cation Transporter 2
- Non-Inhibitor
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- Toxic
- Avian
- Safe
- Bee
- Safe
- Bioconcentration Factor
- 0.64
- Biodegradation
- Safe
- Carcinogenesis
- Toxic
- Crustacean
- Toxic
- Liver Injury I (DILI)
- Toxic
- Eye Corrosion
- Toxic
- Eye Irritation
- Toxic
- Maximum Tolerated Dose
- 1.07
- Liver Injury II
- Toxic
- hERG Blockers
- Safe
- Daphnia Maga
- 5.86
- Micronucleos
- Safe
- NR-AhR
- Safe
- NR-AR
- Safe
- NR-AR-LBD
- Safe
- NR-Aromatase
- Safe
- NR-ER
- Safe
- NR-ER-LBD
- Safe
- NR-GR
- Safe
- NR-PPAR-gamma
- Safe
- NR-TR
- Safe
- T. Pyriformis
- 3.78
- Rat (Acute)
- 2.77
- Rat (Chronic Oral)
- 1.54
- Fathead Minnow
- 5.1
- Respiratory Disease
- Toxic
- Skin Sensitisation
- Toxic
- SR-ARE
- Safe
- SR-ATAD5
- Safe
- SR-HSE
- Toxic
- SR-MMP
- Toxic
- SR-p53
- Safe
General Properties
- Boiling Point
- 170.77
- Hydration Free Energy
- -0.6
- Log(D) at pH=7.4
- 2.07
- Log(P)
- 2.77
- Log S
- -2.57
- Log(Vapor Pressure)
- -0.14
- Melting Point
- -28.53
- pKa Acid
- 6.2
- pKa Basic
- 4.26
No predicted protein targets found for this compound.